{
    "2018-04-16": [
        [
            {
                "time": "2018-04-16",
                "original_text": "药明康德下周二登陆A股 顶格申购需31万市值",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A股",
                        "IPO",
                        "申购"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "下周二打新首只独角兽！药明康德将申购",
                "features": {
                    "keywords": [
                        "药明康德",
                        "独角兽",
                        "打新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德603259中签号是多少 药明康德603259中签号查询",
                "features": {
                    "keywords": [
                        "药明康德",
                        "中签号",
                        "查询"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "传小米下月IPO估值700亿美元 这些概念股值得提前关注",
                "features": {
                    "keywords": [
                        "小米",
                        "IPO",
                        "估值",
                        "概念股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "中概股IPO回A首单 药明康德募资规模或较计划大降63%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "下降"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO募资规模缩水超六成 一季度扣非净利预降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "缩水",
                        "净利润"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "著名制药公司药明康德今日启动A股IPO",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A股",
                        "IPO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "[强于大市评级]中小市值行业研究周报：新股速递：建议关注药明康德",
                "features": {
                    "keywords": [
                        "药明康德",
                        "评级",
                        "新股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO募资规模或较2月预披露计划减少63%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "减少"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO募资规模或较计划大降63%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "下降"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO募资规模大降 独角兽发行监管红线仍在",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "下降",
                        "独角兽",
                        "监管"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "[推荐评级]医药行业点评：药明康德3月28日IPO过会",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "过会",
                        "医药行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO今日正式启动",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "启动"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "医疗保健行业周报：开放医药市场无需恐慌 竞争才能造就伟大企业",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医药市场",
                        "竞争"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "医药生物行业周报：板块迎来调整 积极布局医药分销",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块调整",
                        "分销"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德获IPO批文，检验独角兽投资价值的时候到了",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "批文",
                        "独角兽",
                        "投资价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德IPO拟募资21.3亿元 较原计划减少63%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "募资规模",
                        "减少"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}